BRÈVE publiée le 29/07/2024 à 21:08, il y a 3 mois 22 jours LM Pay S.A. Shareholder General Meeting Report Financial Statements 2023 LM Pay S.A. SGM Discharge Of Duties
COMMUNIQUÉ DE PRESSE publié le 29/07/2024 à 21:03, il y a 3 mois 22 jours LM Pay S.A. Shareholder General Meeting Report LM Pay S.A. held its Ordinary Shareholder General Meeting in Warsaw, reviewing and approving financial statements and discharging duties for 2023 Financial Statements Fintech LM Pay S.A. Discharge Of Duties Shareholder General Meeting
BRÈVE publiée le 18/06/2024 à 10:49, il y a 5 mois 3 jours LM Pay SA publie son rapport annuel audité pour l'exercice 2023 Exercice 2023 Technologie Financière Rapport Annuel LM Pay SA Financement Médical
BRÈVE publiée le 18/06/2024 à 10:49, il y a 5 mois 3 jours LM Pay S.A. Releases Audited Annual Report for FY2023 Annual Report Fintech FY2023 LM Pay S.A. Medical Financing
COMMUNIQUÉ DE PRESSE publié le 18/06/2024 à 10:44, il y a 5 mois 3 jours EQS-Adhoc: LM Pay S.A.: Audited annual report for FY2023 LM Pay S.A. will release audited annual report for FY2023 focusing on financing medical treatments. Report available for download on company website Investor Relations FY2023 Audited Annual Report LM Pay S.A. Financing Medical Treatments
BRÈVE publiée le 29/04/2024 à 18:58, il y a 6 mois 21 jours LM Pay S.A. Reports Continued Growth and Steady Customer Loyalty in Early 2024 Financial Results Revenue Increase Customer Loyalty Fintech Growth LM Pay S.A.
BRÈVE publiée le 29/04/2024 à 18:58, il y a 6 mois 21 jours LM Pay SA annonce une croissance continue et une fidélité constante de ses clients début 2024 Résultats Financiers Augmentation Des Revenus Fidélité Du Consommateur Croissance Des Technologies Financières LM Pay SA
COMMUNIQUÉ DE PRESSE publié le 29/04/2024 à 18:53, il y a 6 mois 21 jours LM Pay’s preliminary figures for FY 2023 and Q1 2024 underpin strong growth and customer loyalty LM Pay's preliminary financial figures for FY 2023 and Q1 2024 show significant revenue growth and customer loyalty, driven by sales intensification and new partnerships Revenue Growth Financial Figures Partnerships Customer Loyalty LM Pay
Publié le 21/11/2024 à 06:58, il y a 7 heures 2 minutes Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 7 heures 2 minutes Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 7 heures 2 minutes Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Publié le 20/11/2024 à 20:07, il y a 17 heures 53 minutes Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Publié le 20/11/2024 à 19:20, il y a 18 heures 40 minutes Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Publié le 21/11/2024 à 13:30, il y a 30 minutes AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Publié le 21/11/2024 à 13:30, il y a 30 minutes Datametrex Secures Additional P.O. Approx $250K for IT Services
Publié le 21/11/2024 à 13:00, il y a 1 heure Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Publié le 21/11/2024 à 13:00, il y a 1 heure Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Publié le 21/11/2024 à 13:00, il y a 1 heure Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Publié le 21/11/2024 à 13:41, il y a 19 minutes Original-Research: Pentixapharm Holding AG (von BankM AG): Kaufen
Publié le 21/11/2024 à 12:35, il y a 1 heure 25 minutes audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Publié le 21/11/2024 à 12:15, il y a 1 heure 45 minutes Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
